Form 4 for ALL Allstate
Accepted 2026-02-26 00:00:00 ET · period of report 2026-02-24 · accession 0000899051-26-000051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-26 | 2026-02-24+ | ALL | Merten Jesse E | PresPersonalProperty-Liability | M - OptEx | $126.93 | +35.2K | 66.3K | +113% | +$4.47M |
| D | 2026-02-26 | 2026-02-24 | ALL | Merten Jesse E | PresPersonalProperty-Liability | F - Tax | $209.82 | -533 | 32.3K | -2% | -$111.8K |
| DM | 2026-02-26 | 2026-02-25 | ALL | Merten Jesse E | PresPersonalProperty-Liability | S - Sale+OE | $208.57 | -34.0K | 33.6K | -50% | -$7.09M |
| DM | 2026-02-26 | 2026-02-24+ | ALL | Merten Jesse E | PresPersonalProperty-Liability | M - OptEx | $0.00 | -35.2K | 9,687 | -78% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-24 | M | A | 1,201 | $0.00 | 32,834 | D | — | — | (F1) Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on February 24, 2027 and February 24, 2028. |
| 2 | Common | Common Stock | 2026-02-24 | F | D | 533 | $209.82 | 32,301 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-25 | M | A | 12,879 | $122.64 | 45,180 | D | — | — | (F2) The option exercise and sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on November 7, 2025. |
| 4 | Common | Common Stock | 2026-02-25 | M | A | 1,734 | $133.00 | 46,914 | D | — | — | (F2) The option exercise and sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on November 7, 2025. |
| 5 | Common | Common Stock | 2026-02-25 | M | A | 19,373 | $137.10 | 66,287 | D | — | — | (F2) The option exercise and sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on November 7, 2025. |
| 6 | Common | Common Stock | 2026-02-25 | S | D | 8,811 | $207.53 | 57,476 | D | — | — | (F2) The option exercise and sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on November 7, 2025. (F3) Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $206.96 to $207.86. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. |
| 7 | Common | Common Stock | 2026-02-25 | S | D | 15,893 | $208.58 | 41,583 | D | — | — | (F2) The option exercise and sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on November 7, 2025. (F4) Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $207.96 to $208.95. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. |
| 8 | Common | Common Stock | 2026-02-25 | S | D | 1,300 | $210.44 | 32,301 | D | — | — | (F2) The option exercise and sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on November 7, 2025. (F6) Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $210.06 to $210.47. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. |
| 9 | Common | Common Stock | 2026-02-25 | S | D | 7,982 | $209.40 | 33,601 | D | — | — | (F2) The option exercise and sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on November 7, 2025. (F5) Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $208.97 to $209.96. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. |
| 10 | Derivative | Restricted Stock Units | 2026-02-24 | M | D | 1,201 | $0.00 | 2,402 | D | — · — to 2028-02-24 | 1,201 Common Stock | (F1) Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on February 24, 2027 and February 24, 2028. |
| 11 | Derivative | Employee Stock Option (Right to Buy) | 2026-02-25 | M | D | 12,879 | $0.00 | 0 | D | $122.64 · 2025-02-17 to 2032-02-17 | 12,879 Common Stock | (F2) The option exercise and sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on November 7, 2025. |
| 12 | Derivative | Employee Stock Option (Right to Buy) | 2026-02-25 | M | D | 1,734 | $0.00 | 868 | D | $133.00 · 2025-10-05 to 2032-10-05 | 1,734 Common Stock | (F2) The option exercise and sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on November 7, 2025. |
| 13 | Derivative | Employee Stock Option (Right to Buy) | 2026-02-25 | M | D | 19,373 | $0.00 | 9,687 | D | $137.10 · 2026-02-16 to 2033-02-16 | 19,373 Common Stock | (F2) The option exercise and sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on November 7, 2025. |